EXHIBIT 32.1

    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report of Elite Pharmaceuticals,  Inc.
(the "Company") on Form 10-Q for the quarter ended September 30, 2004 filed with
the Securities and Exchange  Commission (the "Report"),  I, Bernard Berk,  Chief
Executive Officer of the Company,  certify, pursuant to 18 U.S. C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

         (1) The Report fully complies with the requirements of Section 13(a) of
         the Securities Exchange Act of 1934; and

         (2) The  information  contained in the Report fairly  presents,  in all
         material respects,  the consolidated financial condition of the Company
         as of the dates presented and the consolidated  result of operations of
         the Company for the periods presented.

                                    /s/ Bernard Berk

Date:      November 11, 2004        _____________________________________
                                    Bernard Berk
                                    Chief Executive Officer of
                                    Elite Pharmaceuticals, Inc.


This  certification  has been  furnished  solely  pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.

A signed  original of this  written  statement  required by Section 906 has been
provided  to  Elite  Pharmaceuticals,   Inc.  and  will  be  retained  by  Elite
Pharmaceuticals, Inc. and furnished to the Securities and Exchange Commission or
its staff upon request.